{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:16:20Z","timestamp":1760080580273,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.urology.2021.09.045","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:14:38Z","timestamp":1638922478000},"page":"146-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Prospective Evaluation of Intradetrusor Injections of OnabotulinumtoxinA in Adults With Spinal Dysraphism"],"prefix":"10.1016","volume":"161","author":[{"given":"Alexander","family":"Mackay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Sosland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khue","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Boone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Khavari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.urology.2021.09.045_bib0001","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/1817-1745.85707","article-title":"Spinal dysraphism","volume":"6","author":"Venkataramana","year":"2011","journal-title":"J Pediatr Neurosci"},{"key":"10.1016\/j.urology.2021.09.045_bib0002","doi-asserted-by":"crossref","first-page":"e48399","DOI":"10.1371\/journal.pone.0048399","article-title":"Upper and lower urinary tract outcomes in adult myelomeningocele patients: a systematic review","volume":"7","author":"Veenboer","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.urology.2021.09.045_bib0003","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/nau.22636","article-title":"Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder","volume":"33","author":"Haab","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2021.09.045_bib0004","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.eururo.2012.08.060","article-title":"Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses","volume":"62","author":"Buser","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.09.045_bib0005","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.urology.2014.03.041","article-title":"Urologic problems in spina bifida patients transitioning to adult care","volume":"84","author":"Summers","year":"2014","journal-title":"Urology"},{"issue":"2 Pt 1","key":"10.1016\/j.urology.2021.09.045_bib0006","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1067\/mjd.2000.105567","article-title":"Pharmacology of botulinum toxin","volume":"43","author":"Huang","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.urology.2021.09.045_bib0007","first-page":"63","article-title":"The role of botulinum toxin A in treating neurogenic bladder","volume":"5","author":"Weckx","year":"2016","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urology.2021.09.045_bib0008","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","article-title":"Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity","volume":"187","author":"Ginsberg","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.09.045_bib0009","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","article-title":"Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial","volume":"60","author":"Cruz","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.09.045_bib0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/nau.23025","article-title":"Outcomes of intra-detrusor injections of botulinum toxin in patients with spina bifida: a systematic review","volume":"36","author":"Hascoet","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2021.09.045_bib0011","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0090-4295(77)90168-6","article-title":"Urodynamic evaluation of boy with myelodysplasia and incontinence","volume":"10","author":"Bauer","year":"1977","journal-title":"Urology"},{"key":"10.1016\/j.urology.2021.09.045_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpurol.2014.08.009","article-title":"Botulinum injection is useless on fibrotic neuropathic bladders","volume":"11","author":"Tiryaki","year":"2015","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.urology.2021.09.045_bib0013","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0090-4295(98)00454-3","article-title":"Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL)","volume":"53","author":"Patrick","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.urology.2021.09.045_bib0014","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.juro.2014.01.027","article-title":"The validity and reliability of the neurogenic bladder symptom score","volume":"192","author":"Welk","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.09.045_bib0015","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.urology.2005.12.006","article-title":"Minimal clinically important differences in incontinence quality-of-life scores in stress urinary incontinence","volume":"67","author":"Yalcin","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.urology.2021.09.045_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41393-017-0028-0","article-title":"The Neurogenic Bladder Symptom Score (NBSS): a secondary assessment of its validity, reliability among people with a spinal cord injury","volume":"56","author":"Welk","year":"2018","journal-title":"Spinal Cord"},{"key":"10.1016\/j.urology.2021.09.045_bib0017","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/nau.23501","article-title":"Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: A systematic review","volume":"37","author":"Musco","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2021.09.045_bib0018","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.tjog.2015.10.003","article-title":"Monitoring bladder compliance using end filling detrusor pressure: clinical results and related factors","volume":"54","author":"Liao","year":"2015","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.urology.2021.09.045_bib0019","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.urpr.2018.06.002","article-title":"Outcomes of intradetrusor onabotulinumtoxina injection in adults with congenital spinal dysraphism in tertiary transitional urology clinic","volume":"6","author":"Kaviani","year":"2019","journal-title":"Urol Practice"},{"key":"10.1016\/j.urology.2021.09.045_bib0020","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.juro.2018.05.006","article-title":"Intradetrusor injections of botulinum toxin A in adults with spinal dysraphism","volume":"200","author":"Peyronnet","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.09.045_bib0021","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/bju.13976","article-title":"Intradetrusor onabotulinumtoxinA injections for refractory neurogenic detrusor overactivity incontinence: do we need urodynamic investigation for outcome assessment?","volume":"120","author":"Koschorke","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2021.09.045_bib0022","article-title":"Botulinum toxin-a can be used to manage neurogenic detrusor overactivity in adults with spina bifida but is less effective in the management of poor compliance","volume":"121","author":"Dowling","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2021.09.045_bib0023","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1469-8749.1997.tb07547.x","article-title":"Serum creatinine is a poor marker of glomerular filtration rate in patients with spina bifida","volume":"39","author":"Quan","year":"1997","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.urology.2021.09.045_bib0024","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/JU.0000000000001335","article-title":"Detrusor pressures change with repeat filling cystometry in myelodysplastic children with neurogenic lower urinary tract dysfunction","volume":"205","author":"Ergun","year":"2021","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952101150X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952101150X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:35:20Z","timestamp":1758767720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042952101150X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":24,"alternative-id":["S009042952101150X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2021.09.045","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective Evaluation of Intradetrusor Injections of OnabotulinumtoxinA in Adults With Spinal Dysraphism","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2021.09.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}